Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand? - Wikidata - awgldk - TriplyDB

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

http://www.wikidata.org/entity/Q38638377

about

Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns.

P2860

Q48260381-CBDE4874-0660-4D94-9127-D813D78F97A9

P2860

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

http://www.wikidata.org/entity/Q38638377

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

@en

type

label

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

@en

prefLabel

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

@en

P1433

Q38638377-E85B03CD-5E83-43F6-9AC3-F577957BD8A7

P1476

Q38638377-3716DD0D-789A-4805-8B67-C0571FF32FA2

P2093

Q38638377-86080A36-AA2B-4514-BF14-03282D6EF1E4

Q38638377-FFBC9484-45A4-4E5D-945C-1DDD213E722F

P2860

Q38638377-0245B4B3-A543-4151-A744-47E150AF072B

Q38638377-0539041E-2415-4930-BE56-207BE97E3447

Q38638377-0D0BC79F-FA33-45A2-9A91-772454634EA1

Q38638377-1141140D-91A8-4B0A-9695-6A09F4171A6E

Q38638377-135752E4-194B-42ED-BDCB-D990DB012E23

Q38638377-14A15F0C-7ED6-4FF1-8453-15CB414F0EBC

Q38638377-1F8F0D9D-0DA0-4142-A9D6-DA681C77003A

Q38638377-212B5F5C-3694-4FF5-B770-2D414482A431

Q38638377-2368106D-75E5-410D-A5B3-FD2DFE6525CB

Q38638377-2543EC12-8C46-4DED-9AF9-28379D2C4FFD

P304

Q38638377-BE4B21DB-96EE-4F55-A803-0589CBE9DB8F

P31

Q38638377-D273F6B0-BA72-4981-B890-F61B17B902CB

P356

Q38638377-3C15D2D2-D3D4-4B80-90BD-4666782F8D41

P433

Q38638377-9596A475-D8C0-4AFD-B9C7-C192C09955A6

P478

Q38638377-3D587BA0-B1B9-4D4E-BD56-1343BE938FC8

P50

Q38638377-EE27B9C0-F270-4544-9BD0-1B9C91396849

P577

Q38638377-CA3184E6-A74E-45A4-AD1F-9E3FEAACAFEF

P698

Q38638377-948643A5-3C38-4B10-8A74-7F51C13D316D

P921

Q38638377-A9C7F4F4-DAA6-47AE-9D90-F57C226810D0

P356

P1433

Future Medicinal Chemistry

P1476

Dual/multitargeted xanthone derivatives for Alzheimer's disease: where do we stand?

@en

P2093

Madalena Pinto

http://www.w3.org/2001/XMLSchema#string

Maria I Cruz

http://www.w3.org/2001/XMLSchema#string

P2860

Naturally Occurring Xanthones: Chemistry and Biology

Antioxidant xanthones from the pericarp of Garcinia mangostana (Mangosteen)

Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Screening of non-alkaloidal natural compounds as acetylcholinesterase inhibitors.

Medicinal properties of mangosteen (Garcinia mangostana).

Inflammation, microglia, and Alzheimer's disease.

Anti-angiogenic actions of the mangosteen polyphenolic xanthone derivative α-mangostin

Α-mangostin, a polyphenolic xanthone derivative from mangosteen, attenuates β-amyloid oligomers-induced neurotoxicity by inhibiting amyloid aggregation.

P304

1611-1630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC-2017-0086

http://www.w3.org/2001/XMLSchema#string

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Honorina Cidade

P577

2017-08-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28832188

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease